Combined nivolumab and ipilimumab in non-resectable Merkel cell carcinoma. Saiag P, Blom A. Lancet 2022;400:976-977.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Saiag P, Blom A. Combined nivolumab and ipilimumab in non-resectable Merkel cell carcinoma. Lancet 2022;400:976-977.
PMID: 36108656